Bicocca Open Archive

Logo unimib boa
FAVERIO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.449
AS - Asia 8.907
EU - Europa 7.340
SA - Sud America 1.443
Continente sconosciuto - Info sul continente non disponibili 708
AF - Africa 238
OC - Oceania 30
Totale 34.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.685
SG - Singapore 3.055
IT - Italia 2.443
CN - Cina 1.665
VN - Vietnam 1.481
BR - Brasile 1.067
DE - Germania 1.041
HK - Hong Kong 1.029
RU - Federazione Russa 1.019
SE - Svezia 678
CA - Canada 554
IE - Irlanda 503
GB - Regno Unito 397
IN - India 301
FR - Francia 293
BD - Bangladesh 275
ID - Indonesia 223
FI - Finlandia 193
UA - Ucraina 127
AR - Argentina 122
JP - Giappone 122
AT - Austria 109
ES - Italia 107
MX - Messico 106
TR - Turchia 105
KR - Corea 98
IQ - Iraq 93
NL - Olanda 93
ZA - Sudafrica 86
PK - Pakistan 75
SA - Arabia Saudita 65
CO - Colombia 64
PL - Polonia 64
CH - Svizzera 60
PH - Filippine 51
EC - Ecuador 50
DK - Danimarca 41
BE - Belgio 40
UZ - Uzbekistan 38
MA - Marocco 32
CZ - Repubblica Ceca 30
PY - Paraguay 30
VE - Venezuela 29
AE - Emirati Arabi Uniti 26
CL - Cile 26
AU - Australia 25
JM - Giamaica 25
MY - Malesia 25
KE - Kenya 24
PE - Perù 24
EG - Egitto 22
TH - Thailandia 19
TN - Tunisia 19
JO - Giordania 18
LT - Lituania 17
PT - Portogallo 15
BO - Bolivia 14
CR - Costa Rica 14
ET - Etiopia 13
IL - Israele 13
UY - Uruguay 13
KZ - Kazakistan 12
IR - Iran 11
KG - Kirghizistan 11
PS - Palestinian Territory 11
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
DZ - Algeria 10
HN - Honduras 10
LB - Libano 10
NP - Nepal 9
RO - Romania 9
TW - Taiwan 9
AL - Albania 8
MN - Mongolia 8
NI - Nicaragua 8
SN - Senegal 8
BG - Bulgaria 7
PA - Panama 7
BB - Barbados 6
BY - Bielorussia 6
GR - Grecia 6
HU - Ungheria 6
OM - Oman 6
TT - Trinidad e Tobago 6
EE - Estonia 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
RS - Serbia 5
BH - Bahrain 4
HR - Croazia 4
KH - Cambogia 4
SC - Seychelles 4
SV - El Salvador 4
UG - Uganda 4
CY - Cipro 3
GE - Georgia 3
MD - Moldavia 3
MM - Myanmar 3
PR - Porto Rico 3
Totale 33.354
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.176
Singapore 1.859
Ashburn 1.458
San Jose 1.250
Hong Kong 1.011
Milan 757
Fairfield 687
Chandler 678
Frankfurt am Main 645
Dublin 482
Ho Chi Minh City 449
Wilmington 425
New York 406
Santa Clara 390
Houston 374
Toronto 368
Council Bluffs 355
Hanoi 340
Los Angeles 325
Dallas 321
Woodbridge 307
Chicago 291
Seattle 288
Beijing 257
Cambridge 203
Hefei 187
Princeton 176
Jakarta 173
The Dalles 158
Dearborn 155
Rome 153
Columbus 133
São Paulo 129
Buffalo 119
Helsinki 118
Shanghai 118
Lauterbourg 112
Munich 110
Boardman 109
Jacksonville 89
Moscow 87
Altamura 86
Seoul 84
London 83
Lawrence 81
Nanjing 80
Orem 76
Vienna 74
Tokyo 73
Atlanta 62
Fremont 60
Phoenix 60
Guangzhou 59
San Diego 57
Montreal 56
Da Nang 55
Brooklyn 53
Haiphong 53
Zurich 52
Warsaw 48
Nuremberg 47
Denver 46
Johannesburg 45
Rio de Janeiro 45
Turin 45
Figino 41
Chennai 39
Stockholm 38
Dhaka 37
Brussels 35
Dong Ket 35
Mexico City 35
Monza 35
Turku 34
Bologna 33
Tashkent 33
Boston 31
Lappeenranta 31
Biên Hòa 30
Amsterdam 29
Poplar 29
Baghdad 28
Brasília 28
Jinan 28
Naples 28
Manchester 27
Salt Lake City 27
Washington 27
Hangzhou 26
Lissone 26
Ankara 25
Bắc Ninh 25
Riyadh 25
Belo Horizonte 24
New Delhi 24
Paris 24
Andover 23
Bogotá 23
Charlotte 23
Ha Long 23
Totale 20.737
Salva come PNG Salva come JPEG
Nome #
The ‘Liaisons dangereuses’ Between Lung Cancer and Interstitial Lung Diseases: A Focus on Acute Exacerbation 551
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 535
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 529
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 500
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 470
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 465
Diagnostic delay in bronchiectasis: an Italian perspective 452
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 440
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 433
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study 423
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 419
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 411
Early referral to palliative care services in patients with IPF: A tool to take a step forward 403
A second update on mapping the human genetic architecture of COVID-19 395
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 392
Mapping the human genetic architecture of COVID-19 376
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 371
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 369
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 365
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 363
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 355
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 348
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 347
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 346
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 343
Clinical Characteristics of Anti-synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 334
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 328
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 328
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 323
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 310
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 308
Impact of traffic-related air pollution on pulmonary oxidative stress 307
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 306
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 304
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 300
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 300
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 300
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 298
Janus-faced amiodarone-induced pneumopathy 298
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 298
A 61-year-old female with chronic cough and purulent sputum 296
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 291
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 290
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 288
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 288
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 286
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 285
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 283
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 279
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 278
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 278
A multidisciplinary approach to screen the post-COVID-19 conditions 274
The management of community-acquired pneumonia in the elderly 258
Therapeutic Management of Bronchiectasis in Children and Adolescents: A Concise Narrative Review 257
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 257
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 255
Individualizing duration of antibiotic therapy in community-acquired pneumonia 255
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 255
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians 255
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 255
History of lung volume reduction procedures 254
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 254
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 250
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 249
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 247
Hospital admission decision for patients with community-acquired pneumonia 246
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 244
Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis 240
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 238
Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case–Control Study 234
Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population 233
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases 233
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 230
Evaluation of preoperative cardiopulmonary reserve and surgical risk of patients undergoing lung cancer resection 229
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 228
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 226
Clinical differences in sarcoidosis patients with and without lymphoma: A single-centre retrospective cohort analysis 224
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 223
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 222
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 222
Long-term prognosis in community-acquired pneumonia 221
Clinical Impact of Vaping 219
Cystic lung in sarcoidosis: Clinico-radiologic characteristic and evolution 216
Idiopathic interstitial pneumonia in a patient with von Hippel-Lindau syndrome: a first case 213
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients 213
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 212
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers 208
How do Climate Conditions and Urbanization Impact Non-Tuberculous Mycobacteria Infections? An Italian nationwide case-control study 205
Questionnaires May Help Pulmonologists for Referral of Patients With IPF to a Holistic Approach 204
Long-term macrolides in diffuse interstitial lung diseases 201
Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update 199
Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan 198
Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders 197
Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia 194
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres 193
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 192
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancements 192
Diagnostic Management of Pediatric Bronchiectasis: A Literature Review and Clinical Examples 187
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients 186
Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function 185
Totale 29.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.433 0 0 230 174 100 159 75 122 74 98 134 267
2022/20232.658 278 694 307 232 191 386 44 185 170 27 82 62
2023/20241.960 54 74 123 100 239 452 339 96 121 52 39 271
2024/20255.505 300 557 293 261 431 334 375 234 564 888 510 758
2025/202614.456 1.882 827 998 1.575 1.572 722 2.010 659 1.168 1.141 756 1.146
2026/20271.970 660 904 406 0 0 0 0 0 0 0 0 0
Totale 34.115